Ching-Hung Lin

9PUBLICATIONS

66CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Environmental epidemiologyHaematological tumoursDisease surveillance

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Jul 06, 2026

2025 Update of the Taiwan Expert Consensus on Hormone Receptor-Positive Metastatic Breast Cancer Management.

|Mar 05, 2025

Benefit of adjuvant chemotherapy for T1cN0M0 and selected T1bN0M0 triple-negative breast cancer: a nationwide cancer registry-based study.

Chiao Lo, Dwan-Ying Chang, Yen-Shen Lu

|Jul 05, 2024

Interaction of base excision repair gene polymorphism and estrogen-DNA adducts in breast cancer risk among East Asian women.

Hsing-Wu Chen, Wen-Hung Kuo, Yen-Shen Lu

|Sep 22, 2023

Disparity in survival benefits of pembrolizumab between Asian and non-Asian patients with advanced cancers: A systematic review and meta-regression analysis.

Shang-Hsuan Peng, Ching-Hung Lin, I-Chun Chen

|Aug 08, 2023

Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel.

Joanne Wing Yan Chiu, Soo Chin Lee, James Chung-Man Ho

|Dec 14, 2022

Estrogen-DNA Adducts and Breast Cancer Risk in Premenopausal Asian Women.

Ching-Hung Lin, Muhammad Zahid, Wen-Hung Kuo

Pageof 2

Frequent Collaborators

Yen-Shen Lu

I-Chun Chen

Ching-Hsuan Chen

Wei-Wu Chen

Chiun-Sheng Huang

Ann-Lii Cheng

Ta-Chung Chao

Wen-Hung Kuo

Fu-Chang Hu

Ming-Yang Wang

Frequent Collaborators

Yen-Shen Lu

I-Chun Chen

Ching-Hsuan Chen

Wei-Wu Chen